Cost Comparison of Linezolid Versus Vancomycin for Treatment of Complicated Skin and Skin-Structure Infection Caused by Methicillin-Resistant Staphylococcus aureus in Quebec

BACKGROUND: In Canada, complicated skin and skin-structure infection (cSSSI) caused by methicillin-resistant Staphylococcus aureus (MRSA) is usually treated with antibiotics in hospital, with a follow-up course at home for stable patients. The cost implications of using intravenous and oral linezoli...

Full description

Saved in:
Bibliographic Details
Main Authors: Martine Pettigrew, Daniel JG Thirion, Michael Libman, Giovanni Zanotti
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2012/585603
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561280138870784
author Martine Pettigrew
Daniel JG Thirion
Michael Libman
Giovanni Zanotti
author_facet Martine Pettigrew
Daniel JG Thirion
Michael Libman
Giovanni Zanotti
author_sort Martine Pettigrew
collection DOAJ
description BACKGROUND: In Canada, complicated skin and skin-structure infection (cSSSI) caused by methicillin-resistant Staphylococcus aureus (MRSA) is usually treated with antibiotics in hospital, with a follow-up course at home for stable patients. The cost implications of using intravenous and oral linezolid instead of intravenous vancomycin in Canadian clinical practice have not been examined.
format Article
id doaj-art-48bfa3f6dbb8453fb5bb84d1faa48fc1
institution Kabale University
issn 1712-9532
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Canadian Journal of Infectious Diseases and Medical Microbiology
spelling doaj-art-48bfa3f6dbb8453fb5bb84d1faa48fc12025-02-03T01:25:23ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322012-01-0123418719510.1155/2012/585603Cost Comparison of Linezolid Versus Vancomycin for Treatment of Complicated Skin and Skin-Structure Infection Caused by Methicillin-Resistant Staphylococcus aureus in QuebecMartine Pettigrew0Daniel JG Thirion1Michael Libman2Giovanni Zanotti3Symbiose Partenariat Stratégique Inc, Université de Montréal, CanadaMcGill University Health Centre and Faculté de pharmacie, Université de Montréal, CanadaDivision of Infectious Diseases, Department of Microbiology, McGill University, Montreal, CanadaHealth Economics & Outcomes Research, Pfizer Canada Inc, Kirkland, Quebec, CanadaBACKGROUND: In Canada, complicated skin and skin-structure infection (cSSSI) caused by methicillin-resistant Staphylococcus aureus (MRSA) is usually treated with antibiotics in hospital, with a follow-up course at home for stable patients. The cost implications of using intravenous and oral linezolid instead of intravenous vancomycin in Canadian clinical practice have not been examined.http://dx.doi.org/10.1155/2012/585603
spellingShingle Martine Pettigrew
Daniel JG Thirion
Michael Libman
Giovanni Zanotti
Cost Comparison of Linezolid Versus Vancomycin for Treatment of Complicated Skin and Skin-Structure Infection Caused by Methicillin-Resistant Staphylococcus aureus in Quebec
Canadian Journal of Infectious Diseases and Medical Microbiology
title Cost Comparison of Linezolid Versus Vancomycin for Treatment of Complicated Skin and Skin-Structure Infection Caused by Methicillin-Resistant Staphylococcus aureus in Quebec
title_full Cost Comparison of Linezolid Versus Vancomycin for Treatment of Complicated Skin and Skin-Structure Infection Caused by Methicillin-Resistant Staphylococcus aureus in Quebec
title_fullStr Cost Comparison of Linezolid Versus Vancomycin for Treatment of Complicated Skin and Skin-Structure Infection Caused by Methicillin-Resistant Staphylococcus aureus in Quebec
title_full_unstemmed Cost Comparison of Linezolid Versus Vancomycin for Treatment of Complicated Skin and Skin-Structure Infection Caused by Methicillin-Resistant Staphylococcus aureus in Quebec
title_short Cost Comparison of Linezolid Versus Vancomycin for Treatment of Complicated Skin and Skin-Structure Infection Caused by Methicillin-Resistant Staphylococcus aureus in Quebec
title_sort cost comparison of linezolid versus vancomycin for treatment of complicated skin and skin structure infection caused by methicillin resistant staphylococcus aureus in quebec
url http://dx.doi.org/10.1155/2012/585603
work_keys_str_mv AT martinepettigrew costcomparisonoflinezolidversusvancomycinfortreatmentofcomplicatedskinandskinstructureinfectioncausedbymethicillinresistantstaphylococcusaureusinquebec
AT danieljgthirion costcomparisonoflinezolidversusvancomycinfortreatmentofcomplicatedskinandskinstructureinfectioncausedbymethicillinresistantstaphylococcusaureusinquebec
AT michaellibman costcomparisonoflinezolidversusvancomycinfortreatmentofcomplicatedskinandskinstructureinfectioncausedbymethicillinresistantstaphylococcusaureusinquebec
AT giovannizanotti costcomparisonoflinezolidversusvancomycinfortreatmentofcomplicatedskinandskinstructureinfectioncausedbymethicillinresistantstaphylococcusaureusinquebec